Thats because, for all their efficacy in suppressing appetite and slowing gastric emptying, GLP-1 agonists dont show people how to eat in a healthy, sustainable way, nor do they inspire people to increase activity levels
The Proglucagon Family All three peptidesGLP-1, GLP-2, and GLP-3come from the same genetic source but are processed differently: In the pancreas: Proglucagon is processed to produce glucagon In the intestines: Proglucagon is processed to produce GLP-1, GLP-2, and other peptides In the brain: Similar processing occurs with various effects on appetite and metabolism Now, lets explore each peptide individually to understand their unique characteristics
Neurobiol Learn Mem 96:583-595
YH: Methodology, Writing review & editing
Sobo will review your medical history, goals, current medications, weight history, and risk factors to determine whether GLP-1 therapy is appropriate
Impairment of lipophagy by PNPLA1 mutations causes lipid droplet accumulation in primary fibroblasts of Autosomal Recessive Congenital Ichthyosis patients